Jazz’s CNS Pipeline Demonstrates Transformation

With a first-in-class cannabis-derived treatment for epilepsy, a market-leading treatment for sleep disorders and now a foray into movement disorders, Jazz’s CNS pipeline is strong.

CNS Pills Bottle
Jazz Pharmaceuticals' CNS Pipeline Is Growing • Source: Zhanna Hapanovich

More from Market Intelligence

More from In Vivo